Faron Pharmaceuticals Oy (LON:FARN) Shares Pass Below 50 Day Moving Average – Here’s Why

Faron Pharmaceuticals Oy (LON:FARN)’s share price passed below its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of GBX 180.10 ($2.34) and traded as low as GBX 175 ($2.27). Faron Pharmaceuticals Oy shares last traded at GBX 175 ($2.27), with a volume of 1,173 shares changing hands.

Faron Pharmaceuticals Oy Trading Up 1.4 %

The firm has a market capitalization of £234.94 million, a P/E ratio of -4.68 and a beta of 0.36. The firm has a fifty day simple moving average of GBX 180.10 and a two-hundred day simple moving average of GBX 186.35. The company has a debt-to-equity ratio of 922.55, a current ratio of 1.45 and a quick ratio of 1.09.

About Faron Pharmaceuticals Oy

Faron (AIM: FARN, First North: FARON) is a clinical stage biopharmaceutical company developing novel treatments for medical conditions with significant unmet needs. The Company currently has a pipeline based on the receptors involved in regulation of immune response in oncology and organ damage. Clevegen (bexmarilimab), its investigative precision immunotherapy, is a novel anti-Clever-1 antibody with the ability to switch immune suppression to immune activation in various conditions, with potential across oncology, infectious disease and vaccine development.